Trillium Therapeutics Overview

Trillium Therapeutics Other Income Expense Net

Other Income/Expense Net for TRIL.

Quarterly Other Income/Expense

$194000.00

↑ 100.44% YoY

As of Sep 30, 2021

Annual Other Income/Expense (TTM)

$134.63M

↑ 197.9% YoY

Trailing 12 months ending Sep 30, 2021

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin